European views on patients directly obtaining their laboratory test results
-
Ian D. Watson
, Joanna Siodmiak
Abstract
Background: Medicine is a highly professionalized endeavour, by tradition centred on the authority of physicians. Better education and the advent of the information age cater for increased demands on society in general and on health care in particular to enable people to make informed decisions regarding themselves. Participation in medical decisions requires informed knowledge which is hard to obtain without substantial and time consuming professional help.
Methods: We performed a survey amongst the member organizations of European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) in order to investigate the recognition and preparedness of providing help to patients in interpreting their laboratory results.
Results: Out of 40 EFLM Member Societies, 27 sent their responses to the survey. In most cases the first line delivery of laboratory results to physicians is by computer link (63%). Patients receive their laboratory results on demand from their physician in 60% of cases. However, 34% of laboratory specialists showed a negative attitude for delivering laboratory results to patients. Yet, in 48% of countries 1–5 patients per day ask a laboratory specialist about the significance of laboratory results outside the reference range. When patients are informed about the purpose of laboratory testing, they seek information primarily from their physician, followed by the internet and the Specialist in Laboratory Medicine.
Conclusions: Changing practices increasingly enabling patient access to their records are on the increase facilitated by recent innovations in information technologies. Successful transfer of some of the responsibilities of physicians, demands a mutual triangular dialogue between the patient, their physician and laboratory medicine.
Introduction
There is a decisive move towards a patient-centred approach to medicine including increased patient independence and involvement [1]. Laboratory medicine is a key element in the diagnosis, monitoring and intervention of patients; currently this contribution to patient care is almost exclusively through their physician. However, an increasing body of evidence shows that empowering patients in their own health care has a positive impact; in the realm of laboratory medicine this may, e.g., be exemplified by the widespread acceptance of self-monitoring of blood glucose [2] and INR [3] which even include measurable economic benefits [4].
Countries differ in how patients access their patient records including laboratory results and how they receive corresponding information including interpretation. For several patients suffering from chronic diseases there is a crucial ongoing need for monitoring treatment progress using laboratory test results. Such patients are often motivated to engage in managing their condition, indeed may extend that engagement to their family and carers. While accepting that literacy, numeracy, intelligence and other factors will determine to what extent patients may be able to engage [5], it is true that most have the inherent ability to do so; some of this is aided by the way such data is presented [6, 7].
However, the model of medical paternalism is changing, with increasing recognition that patients need to be engaged in their care, including access to their medical records, also including the results of laboratory-, imaging- and other investigations [8]. There is increasing expectation that this will be so and indeed in some cases enacted or about to be [9, 10]; in other jurisdictions patients present to laboratories and provide their results for their physician to consider. In all these scenarios there is an expectation that the clinician will provide the necessary advice and interpretation to the patient. However, if there is an increasing expectation from patients, as seen with access to internet diagnostics [11], then there will be an increased burden on front-line physicians; there is therefore a role needing fulfilled to provide appropriate contextual interpretations to patients; if this is so are specialists in laboratory medicine willing or able to take on such a role?
The aim of this study was to get a perception on laboratory professionals’ views to delivering laboratory results directly to patients, as well as to perceive the current status of these issues in Europe. We report the results of a survey based on responses received from member associations of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) to assess recognition of such an eventuality.
Materials and methods
A questionnaire was prepared by the EFLM Working Group on Patient Focused Laboratory Medicine (WG-PFLM) (see Appendix) and distributed to all member societies (n=40), responses were confirmed through the EFLM member association National Representatives to confirm they were a reasonable reflection of current practice and views in that country.
Where more than one response was received from a country a median response was derived.
Results
Responses were received from 27 countries (68%). Countries that took a part in the project were France, Belgium, Turkey, UK, Poland, The Netherlands, Serbia, Sweden, Norway, Ukraine, Albania, Croatia, Slovakia, Lithuania, Bosnia and Herzegovina, Ireland, Russian Federation, Italy, Slovenia, Germany, Iceland, Spain, Switzerland, Greece, Montenegro, Finland, and Austria. Results of the study show that in most cases the first-line delivery of laboratory results to physicians is by computer link (63%), patients bringing the results (21%), e-mail (13%) followed by fax (2%) and ordinary mail (1%); the most frequent secondary and tertiary transmission through these modes were e-mail (42%) and fax (38%), respectively.
In 60% of cases, patients received their laboratory result from physicians only after asking for them, but this was not allowed for 16% or it was allowed only in special occasions (24%).
The survey suggested that 1–5 patients per day ask laboratory specialists about the significance of laboratory results outside the reference range. This was noted in 48% of cases.
There is some legislation or regulations in 89% of countries on whether patients can receive their results; in more than a half of the analyzed countries there are no legal impediments to delivering and interpreting laboratory results to patients; but in some cases the laboratory specialists did not know if there were restrictions. Of laboratory specialists 34% showed a negative attitude with the need to deliver laboratory results to patients.
Clinical interpretative comments added by a specialist in laboratory medicine to the report for physicians can be seen by the majority of patients. Unqualified access to unmodified comments were enabled in 49%, but not allowed in 24% of respondent countries, the remainder had varying qualified access (Figure 1).

Availability of clinical interpretative comments added to laboratory test results intended to medical professionals to patients, with and without modification.
An integral part of some chronic disease monitoring is laboratory testing, yet only a small majority of patients (54%) are made aware of this fact (Figure 2).

Are European patients informed about the laboratory tests used for their chronic disease monitoring?
When patients have been informed of why tests were done there was equal interest between those with acute and chronic presentations. Patients seek information from a number of sources. Their prime sources are their physician, the internet and the specialist in laboratory medicine (Table 1).
Percent of answers on patients’ sources of information (more than one response was possible).
Their physician | Internet | Specialist in laboratory medicine | Rarely ask | Other |
---|---|---|---|---|
94 | 64 | 46 | 19 | 3 |
The willingness of EFLM societies to provide results are shown in Table 2.
EFLM member societies willingness (in percentages) to provide more information and interpretation in collaboration with the patient’s physician directly to patients.
Support of EFLM Societies to: | Yes | No | With reservations |
---|---|---|---|
Provide more information directly to patients | 47 | 34 | 19 |
Interpretation of results directly to patients in agreement with the patient’s physician | 46 | 41 | 13 |
Discussion
Changing perspectives enabling patient access to their records, i.e., access to ‘open notes’, is on the increase [12]. Innovations such as My Chart [9] have already proven popular in the USA, and in Denmark patients have access to their own medical record from hospitals including laboratory results [13]. There is a recognized need for interpretation of results to individualize results beyond the quality generic information available from an authoritative site, such as Lab Test on Line [11] and the majority of Laboratory Medicine Societies surveyed are supportive of an approach that enables better patient engagement and comprehension. If there are legal and ethical impediments [14, 15], that is a matter for national governments; for EU countries health is a subsidiarity matter, though cross-border health policy initiatives would be facilitated with patient ownership of their record, including results [16].
Patients want to know about results [17]. In a UK study patients complained of the way results were communicated by administrative staff and the lack of direct health professional engagement [18]. Better communications with patients may enable better use of tests [19]; such an approach fits well with advocated models of integrated care. There is no doubt that patients run a substantial risk of misunderstanding medical information [20] and that there are patient-specific factors that affect comprehension [21]. The main patient-specific factor for laboratory medicine is numeracy [5], this may be addressed by the use of graphs and pictograms [6, 7].
Provision of access to their data requires a patient to have a thorough understanding of the information presented and even improved communication skills [19].
Providing patients with access to their personal health record apart from creating a new health environment for the patient also brings responsibilities for them, particularly social, but also legal and ethical issues [14]. The obligations consequent on the digital revolution also has emotional impact, forcing the patient to confront their illness possibly in the absence of the emotional support, which used to be provided by face-to-face interaction, possibly over extended periods of time [22].
The research in the area of communicating results, while acknowledging the benefits to patients and their engagement, needs to be more progressive with active patient involvement in such research and the implementation of technological communication options [23]. Contrary to expectation, web-based interventions to aid self-monitoring was found to be sub-optimal, yet telephone prompting, i.e., personal contact, improved behaviors [24].
The concept that specialists in laboratory medicine take on the role of laboratory result partner and communicator is not unique, Radiologists are having the same thoughts [25, 26]. Such an approach would require modern and well functioning information technologies. If successful this would transfer some of the burden from physicians, particularly those in primary care; clearly there needs to be a triangular dialogue between the patient, their physician and the clinical support activities, such as radiology and laboratory medicine. Evidently patients expect this to be approached from the perspective of mutuality [27, 28].
This is a potential paradigm shift in laboratory relationships with patients and physicians and there appears to be an appetite for such progress as exemplified by a recent opinion piece in a leading medical journal [29]. We intend to encourage the approaches identified in this paper as advocates and practitioners; we hope many feel enabled and enthused to do the same.
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Financial support: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
Appendix
EFLM Patient Focused Laboratory Medicine Working Group
Questionnaire
How are laboratory results delivered in most cases to physicians in your country? More than one answer can apply. Please rank in order of frequency:
By post
By fax
By computer link
Delivered to patients who bring them to physicians
By email
If the results are delivered directly to the physician, can a patient collect his/her laboratory results on demand?
No
Yes
Yes, in special occasions
N/A
From your experience is there a desire among laboratory specialists in your countryto deliver laboratory results to patients? Please make an estimation:
No
Yes <25%
Yes 25%–50%
Yes 50%–75%
Yes
No answer
Are there any legal issues about delivering and interpreting laboratory results to patients in your country?
No
Yes
No answer
Do patients ask laboratory specialists about the significance of laboratory results outside the reference range and how frequently?
No
Yes >5 patients per day
Yes, 1–5 patients per day
No answer
Are clinical interpretative comments added to the results report by the laboratory professional?
Yes
No
Sometimes
No answer
Are the clinical interpretative comments the same for physicians and for patients?
Yes
No, for patients they are simplified
No, reports issued to patients upon their request do not contain any comments
Patients do not receive results
Other (please comment)
Which patients usually ask about the significance of the results of requested laboratory analysis?
Chronic patients
Patients with acute problems
Both
No answer
Are chronic patients informed about the significance of laboratory parameters used for monitoring of their condition?
Most of the times they are
Most of the times they are not
Approximately there is the equal number of both
No answer
Are patients allowed to request laboratory analysis on their own expense?
No
Yes
No answer
How do patients get information about why tests are performed? More than one answer can apply.
From their physician
Internet
Ask and from the laboratory specialist
Rarely ask
Other (please specify)
From your experience, if patients can get their results from the laboratory, how do they get an interpretation? More than one answer can apply. Please sort in order of frequency:
From their physician
From the laboratory specialist
From the internet
Other information service
How are these reports delivered to the patient? More than one answer can apply. Please rank in order of frequency:
By post/email to the patient personally
The patient must collect them personally in the laboratory
Anyone can collect them in the laboratory
The patient can specify to the laboratory who will collect report
Would your professional society support providing more information directly to patients?
Yes
No
No answer or comment only
Does your professional society support providing interpretation of results directly to patients (with the agreement of the patient’s physician)?
Yes
No
No answer or comment only
Does your professional society support the use of self monitoring of relevant laboratory tests?
Yes
No
No answer or comment only
Are laboratory professionals involved in helping patients to perform self monitoring of laboratory tests?
No answer or comment only
No
Yes by: recommending good test equipment, teaching the patient how to handle the equipment, performing quality assurance of the equipment, discussing problems experienced by the patients
Does the clinical doctor decide at which location the blood samples are to be taken, or can the patient choose the most convenient location (e.g. the laboratory closest to their work or home)?
Yes
No
No answer or comment only
Highest degree:
Public or Private laboratory?
References
1. Dwamena F, Holmes-Rovner M, Gaulden CM, Jorgenson S, Sadigh G, Sikorskii A, et al. Interventions for providers to promote a patient-centred approach in clinical consultations. Cochrane DB Syst Rev 2012;12:CD003267.10.1002/14651858.CD003267.pub2Search in Google Scholar
2. Schnell O, Alawi H, Battelino T, Ceriello A, Diem P, Felton A, et al. Addressing schemes of self-monitoring of blood glucose in type 2 diabetes: a European perspective and expert recommendation. Diabetes Technol Ther 2011;13:959–65.10.1089/dia.2011.0028Search in Google Scholar
3. Heneghan C, Ward A, Perera R, Self-Monitoring Trialist Collaboration, Bankhead C, Fuller A, et al. Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data. Lancet 2012;379:322–34.10.1016/S0140-6736(11)61294-4Search in Google Scholar
4. Craig JA, Chaplin S, Jenks M. Warfarin monitoring economic evaluation of point of care self-monitoring compared to clinic settings. J Med Econ 2014;17:184–90.10.3111/13696998.2013.877468Search in Google Scholar PubMed
5. Woloshin S, Schwartz LM. Communicating data about the benefits and harms of treatment: a randomized trial. Ann Intern Med 2011;155:87–96.10.7326/0003-4819-155-2-201107190-00004Search in Google Scholar PubMed
6. Fuller R, Dudley N, Blacktop J. How informed is consent? Understanding of pictorial and verbal probability information by medical inpatients. Postgrad Med J 2002;78:543–4.10.1136/pmj.78.923.543Search in Google Scholar PubMed PubMed Central
7. Zikmund-Fisher BJ, Witteman HO, Dickson M, Fuhrel-Forbis A, Kahn VC, Exe NL, et al. Blocks, ovals, or people? Icon type affects risk perceptions and recall of pictographs. Med Decis Making 2014;34:443–53.10.1177/0272989X13511706Search in Google Scholar PubMed PubMed Central
8. Fisher B. Patients’ access to their electronic record: offer patients access as soon as you can. Br J Gen Pract 2013;63:E423–5.10.3399/bjgp13X668384Search in Google Scholar PubMed PubMed Central
9. MyChart. Available from: https://www.mychartweb.com/MyChart/default.asp. Accessed 28 March, 2015.Search in Google Scholar
10. UK Department of Health. Major new report on digital technology. Available from: https://www.gov.uk/government/news/major-new-report-on-digital-technology. Accessed 28 March, 2015.Search in Google Scholar
11. Lab Tests Online – UK. Available from: http://www.labtestsonline.org.uk. Accessed 28 March, 2015.Search in Google Scholar
12. Walker J, Darer JD, Elmore JG, Delbanco T. The road toward fully transparent medical records. N Engl J Med 2014;370:6–8.10.1056/NEJMp1310132Search in Google Scholar PubMed
13. Sundhedsstyrelsen. Available from: https://www.sundhed.dk/. Accessed 28 March, 2015.Search in Google Scholar
14. Cushman R, Froomkin AM, Cava A, Abril P, Goodman KW. Ethical, legal and social issues for personal health records and applications. J Biomed Inform 2010;43:S51–5.10.1016/j.jbi.2010.05.003Search in Google Scholar PubMed
15. Vautrey R. Patients’ access to their electronic record: proceed with caution. Br J Gen Pract 2013;63:327–8.10.3399/bjgp13X668393Search in Google Scholar PubMed PubMed Central
16. Kharrazi H, Chisholm R, VanNasdale D, Thompson B. Mobile personal health records: an evaluation of features and functionality. Int J Med Inform 2012;81:579–93.10.1016/j.ijmedinf.2012.04.007Search in Google Scholar PubMed
17. Baldwin AS, Cvengros JA, Christensen AJ, Ishani A, Kaboli PJ. Preferences for a patient-centered role orientation: association with patient-information-seeking behavior and clinical markers of health. Ann Behav Med 2008;35:80–6.10.1007/s12160-007-9011-xSearch in Google Scholar PubMed
18. Cunningham DE, McNab D, Bowie P. Quality and safety issues highlighted by patients in the handling of laboratory test results by general practices – a qualitative study. BMC Health Serv Res 2014;14:1–16.10.1186/1472-6963-14-206Search in Google Scholar PubMed PubMed Central
19. de Almeida Moura J, Costa BC, de Faria RM, Soares TF, Moura EP, Chiappelli F. Improving communication skill training in patient centered medical practice for enhancing rational use of laboratory tests: the core of bioinformation for leveraging stakeholder engagement in regulatory science. Bioinformation 2013;9:718–20.10.6026/97320630009718Search in Google Scholar PubMed PubMed Central
20. Keselman A, Smith CA. A classification of errors in lay comprehension of medical documents. J Med Bioinform 2012;45:1151–63.10.1016/j.jbi.2012.07.012Search in Google Scholar PubMed PubMed Central
21. Buetow S, Kiata L, Liew T, Kenealy T, Dovey S, Elwyn G. Approaches to reducing the most important patient errors in primary health-care: patient and professional perspectives. Health Soc Care Comm 2010;18:296–303.10.1111/j.1365-2524.2009.00904.xSearch in Google Scholar PubMed
22. Lupton D. The digitally engaged patient: self-monitoring and self-care in the digital health era. Soc Theor Health 2013;11:256–70.10.1057/sth.2013.10Search in Google Scholar
23. Belanger E, Bartlett G, Dawes M, Rodriguez C, Hasson-Gidoni I. Examining the evidence of the impact of health information technology in primary care: an argument for participatory research with health professionals and patients. Int J Med Inform 2012;81:654–61.10.1016/j.ijmedinf.2012.07.008Search in Google Scholar PubMed
24. Greaney ML, Sprunck-Harrild K, Bennett GG, Puleo E, Haines J, Viswanath KV, et al. Use of email and telephone prompts to increase self-monitoring in a web-based intervention: randomized controlled trial. J Med Internet Res 2012;14:76–86.10.2196/jmir.1981Search in Google Scholar PubMed PubMed Central
25. Lown BA, Sasson JP, Hinrichs P. Patients as partners in radiology education: an innovative approach to teaching and assessing patient-centered communication. Acad Radiol 2008;15:425–32.10.1016/j.acra.2007.12.001Search in Google Scholar PubMed
26. Rubin DL. Informatics methods to enable patient-centered radiology. Acad Radiol 2009;16:524–34.10.1016/j.acra.2009.01.009Search in Google Scholar PubMed
27. Gittell JH, Godfrey M, Thistlethwaite J. Interprofessional collaborative practice and relational coordination: improving healthcare through relationships. J Interprof Care 2013;27:210–3.10.3109/13561820.2012.730564Search in Google Scholar PubMed
28. Wibe T, Helleso R, Slaughter L, Ekstedtaf M. Lay people’s experiences with reading their medical record. Soc Sci Med 2011;72:1570–3.10.1016/j.socscimed.2011.03.006Search in Google Scholar PubMed
29. O’Kane M, Freedman D, Zikmund-Fisher BJ. Can patients use test tesults effectively if they have direct access? Br Med J 2015;350:h673.10.1136/bmj.h673Search in Google Scholar PubMed
©2015 by De Gruyter
Articles in the same Issue
- Frontmatter
- Editorial
- Biomarkers of inflammatory bowel disease: ready for prime time?
- Review
- Discriminant indices for distinguishing thalassemia and iron deficiency in patients with microcytic anemia: a meta-analysis
- Mini Reviews
- Cell-free DNA for diagnosing myocardial infarction: not ready for prime time
- The Laboratory Medicine and the care of patients infected by the Ebola virus. Experience in a reference hospital of Madrid, Spain
- Opinion Papers
- Theranos phenomenon − part 2
- Considerations in parathyroid hormone testing
- Quantity quotient reporting. Comparison of various models
- Genetics and Molecular Diagnostics
- Assessing quality and functionality of DNA isolated from FFPE tissues through external quality assessment in tissue banks
- Influence of storage conditions and extraction methods on the quantity and quality of circulating cell-free DNA (ccfDNA): the SPIDIA-DNAplas External Quality Assessment experience
- Non-invasive fetal ABO genotyping in maternal plasma using real-time PCR
- Screening non-deletion α-thalassaemia mutations in the HBA1 and HBA2 genes by high-resolution melting analysis
- General Clinical Chemistry and Laboratory Medicine
- European views on patients directly obtaining their laboratory test results
- Diagnostic performances of clinical laboratory tests using Triton X-100 to reduce the biohazard associated with routine testing of Ebola virus-infected patients
- Thrombin generation, D-dimer and protein S in uncomplicated pregnancy
- Multi-analyte analysis of non-vitamin K antagonist oral anticoagulants in human plasma using tandem mass spectrometry
- Second generation analysis of antinuclear antibody (ANA) by combination of screening and confirmatory testing
- Faecal leukocyte esterase activity is an alternative biomarker in inflammatory bowel disease
- Reference Values and Biological Variations
- Total folate and 5-methyltetrahydrofolate in the cerebrospinal fluid of children: correlation and reference values
- Effect of age and gender on reference intervals of red blood cell distribution width (RDW) and mean red cell volume (MCV)
- Infectious Diseases
- Inosine triphosphate pyrophosphohydrolase activity: more accurate predictor for ribavirin-induced anemia in hepatitis C infected patients than ITPA genotype
- The ratio of calprotectin to total protein as a diagnostic and prognostic marker for spontaneous bacterial peritonitis in patients with liver cirrhosis and ascites
- Letter to the Editors
- Misleading high-sensitivity troponin algorithm for NSTEMI in the ESC guidelines
- Adjustment of serum potassium for age and platelet count. A simple step forward towards personalized medicine
- The impact of Tween 20 on repeatability of amyloid β and tau measurements in cerebrospinal fluid
- Effect of storage time and temperature on the generation of reactive oxygen species in peripheral blood leukocytes
- Iohexol interference in the α2-globulin fraction of the serum protein capillary electrophoresis
- A functional variant in the γ-glutamyltransferase (GGT)1 gene is associated with airflow obstruction in smokers
- Comparison of measured venous carbon dioxide and calculated arterial bicarbonates according to the PaCO2 and PaO2 cut-off values of obesity hypoventilation syndrome
- Creatinine, Jaffe, and glucose: another inconvenient truth
- Analytical evaluation of a new liquid immunoturbidimetric assay for the determination of ferritin in serum
- Analytical assessment of the novel homocysteine liquid enzymatic assay on Beckman Coulter AU5800
- Immunoglobulin IgA, IgD, IgG, IgM and IgG subclass reference values in adults
Articles in the same Issue
- Frontmatter
- Editorial
- Biomarkers of inflammatory bowel disease: ready for prime time?
- Review
- Discriminant indices for distinguishing thalassemia and iron deficiency in patients with microcytic anemia: a meta-analysis
- Mini Reviews
- Cell-free DNA for diagnosing myocardial infarction: not ready for prime time
- The Laboratory Medicine and the care of patients infected by the Ebola virus. Experience in a reference hospital of Madrid, Spain
- Opinion Papers
- Theranos phenomenon − part 2
- Considerations in parathyroid hormone testing
- Quantity quotient reporting. Comparison of various models
- Genetics and Molecular Diagnostics
- Assessing quality and functionality of DNA isolated from FFPE tissues through external quality assessment in tissue banks
- Influence of storage conditions and extraction methods on the quantity and quality of circulating cell-free DNA (ccfDNA): the SPIDIA-DNAplas External Quality Assessment experience
- Non-invasive fetal ABO genotyping in maternal plasma using real-time PCR
- Screening non-deletion α-thalassaemia mutations in the HBA1 and HBA2 genes by high-resolution melting analysis
- General Clinical Chemistry and Laboratory Medicine
- European views on patients directly obtaining their laboratory test results
- Diagnostic performances of clinical laboratory tests using Triton X-100 to reduce the biohazard associated with routine testing of Ebola virus-infected patients
- Thrombin generation, D-dimer and protein S in uncomplicated pregnancy
- Multi-analyte analysis of non-vitamin K antagonist oral anticoagulants in human plasma using tandem mass spectrometry
- Second generation analysis of antinuclear antibody (ANA) by combination of screening and confirmatory testing
- Faecal leukocyte esterase activity is an alternative biomarker in inflammatory bowel disease
- Reference Values and Biological Variations
- Total folate and 5-methyltetrahydrofolate in the cerebrospinal fluid of children: correlation and reference values
- Effect of age and gender on reference intervals of red blood cell distribution width (RDW) and mean red cell volume (MCV)
- Infectious Diseases
- Inosine triphosphate pyrophosphohydrolase activity: more accurate predictor for ribavirin-induced anemia in hepatitis C infected patients than ITPA genotype
- The ratio of calprotectin to total protein as a diagnostic and prognostic marker for spontaneous bacterial peritonitis in patients with liver cirrhosis and ascites
- Letter to the Editors
- Misleading high-sensitivity troponin algorithm for NSTEMI in the ESC guidelines
- Adjustment of serum potassium for age and platelet count. A simple step forward towards personalized medicine
- The impact of Tween 20 on repeatability of amyloid β and tau measurements in cerebrospinal fluid
- Effect of storage time and temperature on the generation of reactive oxygen species in peripheral blood leukocytes
- Iohexol interference in the α2-globulin fraction of the serum protein capillary electrophoresis
- A functional variant in the γ-glutamyltransferase (GGT)1 gene is associated with airflow obstruction in smokers
- Comparison of measured venous carbon dioxide and calculated arterial bicarbonates according to the PaCO2 and PaO2 cut-off values of obesity hypoventilation syndrome
- Creatinine, Jaffe, and glucose: another inconvenient truth
- Analytical evaluation of a new liquid immunoturbidimetric assay for the determination of ferritin in serum
- Analytical assessment of the novel homocysteine liquid enzymatic assay on Beckman Coulter AU5800
- Immunoglobulin IgA, IgD, IgG, IgM and IgG subclass reference values in adults